← Back to Search

MR Imaging on the Alberta linac-MR P3 system for Cancer

N/A
Recruiting
Led By Nawaid Usmani, MD
Research Sponsored by AHS Cancer Control Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, approximately 1 year
Awards & highlights

Study Summary

This trial is testing whether a new machine that uses MRI scans to guide radiotherapy treatments can safely acquire high quality images.

Who is the study for?
This trial is for adults over 18 who are fit for high dose radiation therapy as determined by their oncologist. It's not suitable for those unable to lie flat and still during scans, cannot consent, or have conditions that make MRI use unsafe.Check my eligibility
What is being tested?
The study tests the Alberta linac-MR P3 system's ability to safely acquire high-quality MR images at the Cross Cancer Institute. The goal is to improve tumor visualization in radiotherapy using only MRI guidance.See study design
What are the potential side effects?
Since this trial involves MR imaging rather than medication or invasive procedures, side effects may include discomfort from lying still but typically do not involve drug-related reactions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, approximately 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, approximately 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of high-quality MR image data sets acquired for each major tumour site (prostate, liver, lung, CNS, and breast)
Secondary outcome measures
Quantify the patient experience on the Linac-MR

Trial Design

1Treatment groups
Experimental Treatment
Group I: MR Imaging on the Alberta linac-MR P3 systemExperimental Treatment1 Intervention
All participants will undergo a single MR imaging session (30-40 minutes) on the Alberta linac-MR P3 system.

Find a Location

Who is running the clinical trial?

AHS Cancer Control AlbertaLead Sponsor
182 Previous Clinical Trials
36,112 Total Patients Enrolled
Nawaid Usmani, MDPrincipal InvestigatorCross Cancer Institute, Alberta Health Services
3 Previous Clinical Trials
363 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)
2021. "MR Imaging Study Using the Northern Alberta Linac-MR (Northern LIGHTs - 1)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04358913.
~18 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top